Skip to main content

Table 2 Characteristics of confirmed cases of SCLC following the case validation exercise

From: Feasibility and validity of The Health Improvement Network database of primary care electronic health records to identify and characterise patients with small cell lung cancer in the United Kingdom

Characteristic

No. of patients

N = 381

n (%)

Recorded symptoms

322 (84.5)

 Haemoptysis

38 (11.8)

 Chest infection

58 (18.0)

 Cough

51 (15.8)

 Shortness of breath

37 (11.5)

 Chest, abdominal or back pain

49 (15.2)

 COPD/respiratory complications

41 (12.7)

 Abnormal weight loss

13 (4.0)

 Indirect finding

35 (10.9)

First diagnostic procedure recorded

278 (73.0)

 Chest X-ray

182 (65.5)

 CAT scan

49 (17.6)

 Abdominal ultrasound

5 (1.8)

 Bronchoscopy

33 (11.9)

 Biopsy

5 (1.8)

 Other

4 (1.4)

Stage

 Known

242 (63.5)

 Limited

55 (23.7)*

 Extensive

187 (76.3)*

 Unknown

139 (36.5)

Chemotherapy/radiotherapy

 Chemotherapy

212 (55.6)

 Radiotherapy

120 (31.5)

Metastasis

144 (37.8)

Asbestos exposure

11 (2.9)

  1. *Percentage of the 242 cases with recorded stage
  2. Computed tomography scan; CAT, COPD chronic obstructive pulmonary disease, SCLC small cell lung cancer